Rodent models in depression research: Classical strategies and new directions

Annals of Medicine

Volumn 42, Issue 4, 2010, Pages 252-264

  Pollak, Daniela D ^a   Rey, Carlos E ^b   Monje, Francisco J ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Centro Internacional de Fsica (CIF)   (Colombia)

Author keywords

Animal model; Antidepressant; Behavior; Depression; Mood disorder; Translational

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; CITALOPRAM; CYTOKINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; IPRONIAZID; MAPROTILINE; MOCLOBEMIDE; PARGYLINE; PAROXETINE; REBOXETINE;

ANHEDONIA; ANXIETY DISORDER; CHRONIC STRESS; CONSTRUCT VALIDITY; DEPRESSION; DISEASE MODEL; EARLY LIFE STRESS; ENVIRONMENTAL ENRICHMENT; EPIGENETICS; EXPERIMENTAL TEST; EXTERNAL VALIDITY; FACE VALIDITY; FOOTSHOCK; FORCED SWIMMING TEST; GENE TARGETING; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPOPHAGIA; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMMOBILIZATION STRESS; LEARNED HELPLESSNESS; MAJOR DEPRESSION; MATERNAL DEPRIVATION; NONHUMAN; OLFACTORY BULBECTOMY; PATHOGENESIS; PHYSICAL ACTIVITY; PREDICTIVE VALIDITY; PRENATAL STRESS; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SELF STIMULATION; SEROTONINERGIC SYSTEM; SOCIAL INTERACTION; TAIL SUSPENSION TEST; TASTE PREFERENCE; TRANSGENIC MOUSE;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HUMANS; MICE; RATS; RODENTIA; SWIMMING;

EID: 77952229468     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853891003769957     Document Type: Review

References (130)

1. Murray CJL Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press 1996.
2. Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry. 1994;151:979-986
3. Wong ML, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci. 2001;2:343-351
4. Sheps DS, Sheffield D. Depression, anxiety, and the cardiovascular system: the cardiologist's perspective. J Clin Psychiatry. 2001;62 Suppl 8:12-6; discussion 17-18
5. Rumsfeld JS, Ho PM. Depression and cardiovascular disease: a call for recognition. Circulation. 2005;111:250-253
6. Baker CB, Johnsrud MT, Crismon ML, Rosenheck RA, Woods S W. Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry. 2003;183: 498-506.
7. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepres-sants. Arch Intern Med. 2004;164:2367-2370
8. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Phar-macodyn Ther. 1977;229:327-336
9. Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 2005;29:571-625.
10. Dulawa SC, Hen R. Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev. 2005;29:771-783
11. Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev. 2005;29:891-909.
12. Feder A, Nestler EJ, Charney DS. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci. 2009;10: 446-457
13. Forbes NF, Stewart CA, Matthews K, Reid IC. Chronic mild stress and sucrose consumption: validity as a model of depression. Physiol Behav. 1996;60:1481-1484
14. Francis DD, Szegda K, Campbell G, Martin WD, Insel TR. Epigenetic sources of behavioral differences in mice. Nat Neurosci. 2003;6:445-446
15. Millstein RA, Holmes A. Effects of repeated maternal separation on anxiety-and depression-related phenotypes in different mouse strains. Neurosci Biobehav Rev. 2007;31:3-17.
16. Newport DJ, Stowe ZN, Nemeroff CB. Parental depression: animal models of an adverse life event. Am J Psychiatry. 2002;159:1265-1283
17. Song C, Leonard BE. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev. 2005;29: 627-647
18. Vollmayr B, Henn FA. Learned helplessness in the rat: improvements in validity and reliability. Brain Res Brain Res Protoc. 2001;8:1-7.
19. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev. 1992;16:525-534
20. Yadid G, Nakash R, Deri I, Tamar G, Kinor N, Gispan I, et al. Elucidation of the neurobiology of depression: insights from a novel genetic animal model. Prog Neurobiol. 2000;62:353-378
21. Cryan JF, Slattery DA. Animal models of mood disorders: Recent developments. Curr Opin Psychiatry. 2007;20:1-7.
22. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl). 1997;134:319-329
23. van der Staay FJ, Arndt SS, Nordquist RE. Evaluation of animal models of neurobehavioral disorders. Behav Brain Funct. 2009;5:11.
24. Crabbe JC, Wahlsten D, Dudek BC. Genetics of mouse behavior: interactions with laboratory environment. Science. 1999;284:1670-1672
25. Wahlsten D, Metten P, Phillips TJ, Boehm SL 2nd, Burkhart-Kasch S, Dorow J, et al. Different data from different labs: lessons from studies of gene-environment interaction. J Neu-robiol. 2003;54:283-311.
26. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends in pharmacological sciences. 2002;23:238-245
27. Cryan JF, Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modifi ed mice. Mol Psychiatry. 2004;9:326-357
28. Pollak DD, Monje FJ, Zuckerman L, Denny CA, Drew MR, Kandel ER. An animal model of a behavioral intervention for depression. Neuron. 2008;60:149-161
29. Castagne V, Porsolt RD, Moser P. Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse. Eur J Pharmacol. 2009; 616:128-133
30. Popoli M. Agomelatine: innovative pharmacological approach in depression. CNS Drugs. 2009;23 Suppl 2:27-34.
31. Rupniak NM. Animal models of depression: challenges from a drug development perspective. Behav Pharmacol. 2003;14: 385-390
32. Steru L, Chermat R, Thierry B, Mico JA, Lenegre A, Steru M, et al. The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. Prog Neuropsychopharmacol Biol Psychiatry. 1987;11:659-671
33. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl). 1985;85:367-370
34. Perrault G, Morel E, Zivkovic B, Sanger DJ. Activity of lito-xetine and other serotonin uptake inhibitors in the tail suspension test in mice. Pharmacol Biochem Behav. 1992;42:45-47
35. Dulawa SC, Holick KA, Gundersen B, Hen R. Effects of chronic fl uoxetine in animal models of anxiety and depression. Neuropsychopharmacology. 2004;29:1321-1330
36. Kalueff AV, Wheaton M, Murphy DL. What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res. 2007;179:1-18.
37. Reus V. Mental disorders. In: Fauci A, editor. Harrison's Principles of Internal Medicine. Columbus: McGraw-Hill Medical; 2006.
38. Argyropoulos SV, Nutt DJ. Anhedonia and chronic mild stress model in depression. Psychopharmacology (Berl). 1997;134:333-6; discussion 371-377
39. Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology. 1998;18:135-174
40. Jayatissa MN, Bisgaard C, Tingstrom A, Papp M, Wiborg O. Hippocampal cytogenesis correlates to escitalopram-medi-ated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology. 2006;31:2395-2404
41. Strekalova T, Gorenkova N, Schunk E, Dolgov O, Bartsch D. Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behav Pharmacol. 2006;17:271-287
42. Casarotto PC, Andreatini R. Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone. Eur Neuropsychopharmacol. 2007;17: 735-742
43. Wise RA. Addictive drugs and brain stimulation reward. Annu Rev Neurosci. 1996;19:319-340
44. Slattery DA, Markou A, Cryan JF. Evaluation of reward processes in an animal model of depression. Psychopharma-cology (Berl). 2007;190:555-568
45. Cryan JF, Hoyer D, Markou A. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol Psychiatry. 2003;54:49-58.
46. Romeas T, Morissette MC, Mnie-Filali O, Pineyro G, Boye SM. Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression. Psychopharma-cology (Berl). 2009;205:293-303.
47. Moreau JL, Jenck F, Martin JR, Mortas P, Haefely WE. Anti-depressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur Neuropsychopharmacol. 1992;2:43-49
48. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci. 2006;9:519-525
49. Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychophar-macology guidelines. British Association for Psychopharma-cology. J Psychopharmacol. 2000;14:3-20.
50. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, et al. Essential role of BDNF in the mesolim-bic dopamine pathway in social defeat stress. Science. 2006; 311:864-868
51. Kuipers SD, Trentani A, Westenbroek C, Bramham CR, Korf J, Kema IP, et al. Unique patterns of FOS, phospho-CREB and BrdU immunoreactivity in the female rat brain following chronic stress and citalopram treatment. Neuropharmacol-ogy. 2006;50:428-440
52. Swiergiel AH, Leskov IL, Dunn AJ. Effects of chronic and acute stressors and CRF on depression-like behavior in mice. Behav Brain Res. 2008;186:32-40.
53. Haenisch B, Bilkei-Gorzo A, Caron MG, Bonisch H. Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neuro-trophin alterations in two chronic stress models of depression. J Neurochem. 2009;111:403-416
54. Bravo JA, Diaz-Veliz G, Mora S, Ulloa JL, Berthoud VM, Morales P, et al. Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection. Behav Pharmacol. 2009;20:273-285
55. Veena J, Srikumar BN, Raju TR, Shankaranarayana Rao BS. Exposure to enriched environment restores the survival and differentiation of new born cells in the hippocampus and ameliorates depressive symptoms in chronically stressed rats. Neurosci Lett. 2009;455:178-182
56. Parihar VK, Hattiangady B, Kuruba R, Shuai B, Shetty AK. Predictable chronic mild stress improves mood, hippocam-pal neurogenesis and memory. Mol Psychiatry. 2009 Dec 15 (Epub ahead of print).
57. Ito H, Nagano M, Suzuki H, Murakoshi T. Chronic stress enhances synaptic plasticity due to disinhibition in the anterior cingulate cortex and induces hyper-locomotion in mice. Neuropharmacology. 2010;58:746-757
58. Finamore TL, Port RL. Developmental stress disrupts habit-uation but spares prepulse inhibition in young rats. Physiol Behav. 2000;69:527-530
59. Eklund MB, Johansson LM, Uvnas-Moberg K, Arborelius L. Differential effects of repeated long and brief maternal separation on behaviour and neuroendocrine parameters in Wistar dams. Behav Brain Res. 2009;203:69-75.
60. Pihoker C, Owens MJ, Kuhn CM, Schanberg SM, Nemeroff CB. Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary- adrenocortical axis: a putative role for corticotropin-releasing factor. Psychoneuroendo-crinology. 1993;18:485-493
61. Dent GW, Smith MA, Levine S. Stress-induced alterations in locus coeruleus gene expression during ontogeny. Brain Res Dev Brain Res. 2001;127:23-30.
62. Kehoe P, Blass EM. Behaviorally functional opioid systems in infant rats: II. Evidence for pharmacological, physiological, and psychological mediation of pain and stress. Behav Neurosci. 1986;100:624-630 (Pubitemid 17208197) (Pubitemid 17208197)
63. Fabricius K, Wortwein G, Pakkenberg B. The impact of maternal separation on adult mouse behaviour and on the total neuron number in the mouse hippocampus. Brain Struct Funct. 2008;212:403-416
64. Mirescu C, Peters JD, Gould E. Early life experience alters response of adult neurogenesis to stress. Nat Neurosci. 2004;7:841-846
65. Weinberg J, Krahn EA, Levine S. Differential effects of handling on exploration in male and female rats. Dev Psycho-biol. 1978;11:251-259
66. Abraham IM, Kovacs KJ. Postnatal handling alters the activation of stress-related neuronal circuitries. Eur J Neurosci. 2000;12:3003-3014
67. Lovic V, Gonzalez A, Fleming AS. Maternally separated rats show defi cits in maternal care in adulthood. Dev Psychobiol. 2001;39:19-33.
68. Fride E, Weinstock M. The effects of prenatal exposure to predictable or unpredictable stress on early development in the rat. Dev Psychobiol. 1984;17:651-660
69. Drago F, Di Leo F, Giardina L. Prenatal stress induces body weight defi cit and behavioural alterations in rats: the effect of diazepam. Eur Neuropsychopharmacol. 1999;9:239-245
70. Vallee M, Mayo W, Dellu F, Le Moal M, Simon H, Maccari S. Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion. J Neurosci. 1997;17: 2626-2636
71. Henry C, Kabbaj M, Simon H, Le Moal M, Maccari S. Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats. J Neuroendocrinol. 1994;6:341-345
72. Peters DA. Prenatal stress: effect on development of rat brain adrenergic receptors. Pharmacol Biochem Behav. 1984;21: 417-422
73. Maccari S, Morley-Fletcher S. Effects of prenatal restraint stress on the hypothalamus-pituitary-adrenal axis and related behavioural and neurobiological alterations. Psychoneuroen-docrinology. 2007;32 Suppl 1:S10-5.
74. Abe H, Hidaka N, Kawagoe C, Odagiri K, Watanabe Y, Ikeda T, et al. Prenatal psychological stress causes higher emotionality, depression-like behavior, and elevated activity in the hypothalamo-pituitary-adrenal axis. Neurosci Res. 2007; 59:145-151
75. Maccari S, Darnaudery M, Morley-Fletcher S, Zuena AR, Cinque C, Van Reeth O. Prenatal stress and long-term consequences: implications of glucocorticoid hormones. Neurosci Biobehav Rev. 2003;27:119-127
76. Roche M, Shanahan E, Harkin A, Kelly JP. Trans-species assessment of antidepressant activity in a rodent model of depression. Pharmacol Rep. 2008;60:404-408
77. Roche M, Harkin A, Kelly JP. Chronic fl uoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat. Neuropsychopharmacology. 2007;32:1312-1320
78. Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry. 2002;3:69-86.
79. Sherman AD, Sacquitne JL, Petty F. Specifi city of the learned helplessness model of depression. Pharmacol Bio-chem Behav. 1982;16:449-454
80. Hitzemann R. Animal models of psychiatric disorders and their relevance to alcoholism. Alcohol Res Health. 2000;24:149-158
81. Gardier AM, Guiard BP, Guilloux JP, Reperant C, Coudore F, David DJ. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review. Fundam Clin Pharmacol. 2009;23:23-42.
82. Cryan JF, Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov. 2005;4:775-790
83. Alexandre C, Popa D, Fabre V, Bouali S, Venault P, Lesch KP, et al. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J Neurosci. 2006;26:5554-5564
84. Fox MA, Andrews AM, Wendland JR, Lesch KP, Holmes A, Murphy DL. A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychophar-macology (Berl). 2007;195:147-166
85. Groenink L, van Bogaert MJ, van der Gugten J, Oosting RS, Olivier B. 5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety paradigms. Behav Pharmacol. 2003;14:369-383
86. Guilloux JP, David DJ, Guiard BP, Chenu F, Reperant C, Toth M, et al. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outfl ow, but not antide-pressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Neuropsychopharmacology. 2006;31:2162-2172
87. Canli T, Lesch KP. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci. 2007;10:1103-1109
88. Murphy DL, Lesch KP. Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci. 2008;9:85-96.
89. Muigg P, Hoelzl U, Palfrader K, Neumann I, Wigger A, Land-graf R, et al. Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety. Biol Psychiatry. 2007;61:782-796
90. Kohen R, Neumaier JF, Hamblin MW, Edwards E. Congenially learned helpless rats show abnormalities in intracellular signaling. Biol Psychiatry. 2003;53:520-529
91. Touma C, Bunck M, Glasl L, Nussbaumer M, Palme R, Stein H, et al. Mice selected for high versus low stress reactivity: a new animal model for affective disorders. Psychoneuroendocrinology. 2008;33:839-862
92. Overstreet DH, Russell RW, Helps SC, Messenger M. Selective breeding for sensitivity to the anticholinesterase DFP. Psychopharmacology (Berl). 1979;65:15-20.
93. Janowsky DS, Overstreet DH, Nurnberger JI Jr. Is choliner-gic sensitivity a genetic marker for the affective disorders? Am J Med Genet. 1994;54:335-344
94. Overstreet DH, Griebel G. Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat. Pharmacol Biochem Behav. 2005;82:223-227
95. Landgraf R, Wigger A. Born to be anxious: neuroendocrine and genetic correlates of trait anxiety in HAB rats. Stress. 2003;6:111-119
96. Keck ME, Sartori SB, Welt T, Muller MB, Ohl F, Holsboer F, et al. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. J Neuro-chem. 2005;92:1170-1179
97. Frank E, Novick D, Kupfer DJ. Antidepressants and psychotherapy: a clinical research review. Dialogues Clin Neurosci. 2005;7:263-272
98. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462-1470
99. van Praag H, Kempermann G, Gage FH. Neural consequences of environmental enrichment. Nat Rev Neurosci. 2000;1:191-198
100. Nithianantharajah J, Hannan AJ. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci. 2006;7:697-709.
101. Sahay A, Hen R. Adult hippocampal neurogenesis in depression. Nat Neurosci. 2007;10:1110-1115
102. Bruel-Jungerman E, Laroche S, Rampon C. New neurons in the dentate gyrus are involved in the expression of enhanced long-term memory following environmental enrichment. Eur J Neurosci. 2005;21:513-521
103. Koh S, Magid R, Chung H, Stine CD, Wilson DN. Depressive behavior and selective down-regulation of serotonin receptor expression after early-life seizures: reversal by environmental enrichment. Epilepsy Behav. 2007;10: 26-31.
104. Meshi D, Drew MR, Saxe M, Ansorge MS, David D, Santarelli L, et al. Hippocampal neurogenesis is not required for behavioral effects of environmental enrichment. Nat Neurosci. 2006;9:729-731
105. Neeper SA, Gomez-Pinilla F, Choi J, Cotman C. Exercise and brain neurotrophins. Nature. 1995;373:109.
106. Gomez-Pinilla F, Dao L, So V. Physical exercise induces FGF-2 and its mRNA in the hippocampus. Brain Res. 1997;764:1-8.
107. Naylor AS, Bull C, Nilsson MK, Zhu C, Bjork-Eriksson T, Eriksson PS, et al. Voluntary running rescues adult hippoc-ampal neurogenesis after irradiation of the young mouse brain. Proc Natl Acad Sci USA. 2008;105:14632-14637
108. Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res. 2001;120:87-95.
109. Greenwood BN, Strong PV, Brooks L, Fleshner M. Anxietylike behaviors produced by acute fl uoxetine administration in male Fischer 344 rats are prevented by prior exercise. Psychopharmacology (Berl). 2008;199:209-222
110. Chambliss HO, Van Hoomissen JD, Holmes PV, Bunnell BN, Dishman RK. Effects of chronic activity wheel running and imipramine on masculine copulatory behavior after olfactory bulbectomy. Physiol Behav. 2004;82: 593-600.
111. Souetre E, Salvati E, Belugou JL, Pringuey D, Candito M, Krebs B, et al. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobio-logical abnormality. Psychiatry Res. 1989;28:263-278
112. Partonen T, Treutlein J, Alpman A, Frank J, Johansson C, Depner M, et al. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med. 2007;39:229-238
113. Johansson C, Willeit M, Smedh C, Ekholm J, Paunio T, Kieseppa T, et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology. 2003;28:734-739
114. Gonzalez MM, Aston-Jones G. Light deprivation damages monoamine neurons and produces a depressive behavioral phenotype in rats. Proc Natl Acad Sci USA. 2008;105:4898-4903
115. Yirmiya R. Depression in medical illness: the role of the immune system. West J Med. 2000;173:333-336
116. Schaefer M, Winterer J, Sarkar R, Uebelhack R, Franke L, Heinz A, et al. Three cases of successful tryptophan add-on or monotherapy of hepatitis C and IFNalpha-associated mood disorders. Psychosomatics. 2008;49:442-446
117. O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygen-ase activation in mice. Mol Psychiatry. 2009;14:511-522
118. Miller AH, Maletic V, Raison CL. Infl ammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65:732-741
119. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From infl ammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46-56.
120. Brown GW, Craig TK, Harris TO. Parental maltreatment and proximal risk factors using the Childhood Experience of Care & Abuse (CECA) instrument: a life-course study of adult chronic depression\5. J Affect Disord. 2008;110:222-233
121. Uher R. The implications of gene-environment interactions in depression: will cause inform cure? Mol Psychiatry. 2008; 13:1070-1078
122. Renthal W, Nestler EJ. Chromatin regulation in drug addiction and depression. Dialogues Clin Neurosci. 2009;11:257-268
123. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci. 2007; 8:355-367
124. Grayson DR, Kundakovic M, Sharma RP. Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Mol Pharmacol. 2010;77:126-135
125. Crowley JJ, Blendy JA, Lucki I. Strain-dependent antide-pressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology (Berl). 2005;183:257-264
126. Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl). 2001;155:315-322
127. Stock HS, Ford K, Wilson MA. Gender and gonadal hormone effects in the olfactory bulbectomy animal model of depression. Pharmacol Biochem Behav. 2000;67:183-191
128. Delgado MR, Nearing KI, Ledoux JE, Phelps EA. Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron. 2008;59:829-838
129. Pollak DD, Rogan MT, Egner T, Perez DL, Yanagihara TK, Hirsch J. A translational bridge between mouse and human models of learned safety. Ann Med. 2010;42:115-122
130. Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci. 2007;10:1116-1124